Form 8-K - Current report:
SEC Accession No. 0001615219-21-000020
Filing Date
2021-03-03
Accepted
2021-03-03 16:23:39
Documents
3
Period of Report
2021-03-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K salarius2021cmpo-form8xkla.htm 8-K 25143
2 EX-99.1 salarius2021cmpolaunchrele.htm EX-99.1 9664
3 image_01a.jpg GRAPHIC 39936
  Complete submission text file 0001615219-21-000020.txt   91165
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 21709274
SIC: 2834 Pharmaceutical Preparations